CD44 and ovarian carcinoma: Another study conducted in the US also reported that the expression of standard CD44 (CD44s) was significantly associated with worse DFS both in univariate (p = 0.003) and multivariate (p = 0.006) analysis in 56 patients with epithelial ovarian cancer (9).